Display options
Cite
Ghafoory S, Mehrabi A, Hafezi M, et al. Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells. Oncogenesis. 2015;4:e152doi: 10.1038/oncsis.2015.11.
Ghafoory, S., Mehrabi, A., Hafezi, M., Cheng, X., Breitkopf-Heinlein, K., Hick, M., Huichalaf, M., Herbel, V., Saffari, A., & Wölfl, S. (2015). Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells. Oncogenesis, 4e152. https://doi.org/10.1038/oncsis.2015.11
Ghafoory, S, et al. "Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells." Oncogenesis vol. 4 (2015): e152. doi: https://doi.org/10.1038/oncsis.2015.11
Ghafoory S, Mehrabi A, Hafezi M, Cheng X, Breitkopf-Heinlein K, Hick M, Huichalaf M, Herbel V, Saffari A, Wölfl S. Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells. Oncogenesis. 2015 Jun 01;4:e152. doi: 10.1038/oncsis.2015.11. PMID: 26029826; PMCID: PMC4753520.
Copy Download .nbib Format: NLM
Share it on

Oncogenesis. 2015 Jun 01;4:e152. doi: 10.1038/oncsis.2015.11.

Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells.

Oncogenesis

S Ghafoory, A Mehrabi, M Hafezi, X Cheng, K Breitkopf-Heinlein, M Hick, M Huichalaf, V Herbel, A Saffari, S Wölfl

Affiliations

  1. Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
  2. Department of General, Visceral and Transplantation surgery, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
  3. Molecular Hepatology-Alcohol Associated Diseases, II. Medical Clinic, Faculty of Medicine at Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany.

PMID: 26029826 PMCID: PMC4753520 DOI: 10.1038/oncsis.2015.11

Abstract

Expression of E-cadherin has a central role in maintaining epithelial morphology. In solid tumors, reduction of E-cadherin results in disruption of intercellular contacts. Consequently, cells lose adhesive properties and gain more invasive mesenchymal properties. Nevertheless, the mechanism of E-cadherin regulation is not completely elucidated. Here we analyzed the distribution of E-cadherin expression at the cell level in human hepatocellular carcinoma, in which human liver paraffin blocks from 25 hepatocellular carcinoma patients were prepared from cancerous (CA) and noncancerous areas (NCA). In situ hybridization (ISH) was performed to detect E-cadherin and hypoxia-induced factor-1α (HIF1α) mRNAs and immunohistochemistry to stain E-cadherin protein. In parallel, RNA was extracted from CA and NCA, and E-cadherin and HIF1α were quantified by quantitative reverse transcription PCR. ISH revealed abundant E-cadherin mRNA in nuclei of hepatocellular carcinoma cells (HCCs), whereas immunohistochemistry showed depletion of E-cadherin protein from these areas. In sections of NCA, E-cadherin mRNA was also found in the cytosol, and E-cadherin protein was detected on the membrane of cells. Experiments in cell lines confirmed E-cadherin mRNA in nuclei of cells negative for E-cadherin protein. HIF1α expression is elevated in CAs, which is associated with a clear cytosolic staining for this mRNA. Our results demonstrate that E-caderhin mRNA is selectively retained in nuclei of HCCs, whereas other mRNAs are still exported, suggesting that translocation of E-cadherin mRNA from nuclei to cytoplasm has a role in regulating E-cadherin protein levels during epithelial mesenchymal transition.

References

  1. Cancer Sci. 2013 Mar;104(3):398-408 - PubMed
  2. Histopathology. 2012 Aug;61(2):306-13 - PubMed
  3. Mod Pathol. 2001 May;14(5):458-64 - PubMed
  4. Cell Mol Life Sci. 2008 Apr;65(7-8):1133-49 - PubMed
  5. J Cell Sci. 1994 Dec;107 ( Pt 12):3655-63 - PubMed
  6. Breast Cancer Res. 2003;5(6):R217-22 - PubMed
  7. Cell Cycle. 2008 Jul 15;7(14 ):2090-6 - PubMed
  8. Surg Oncol. 2000 Dec;9(4):151-71 - PubMed
  9. APMIS. 2006 Jul-Aug;114(7-8):549-58 - PubMed
  10. PLoS One. 2012;7(9):e46391 - PubMed
  11. J Cancer Res Clin Oncol. 2005 Jan;131(1):14-8 - PubMed
  12. Br J Cancer. 2013 Feb 5;108(2):402-8 - PubMed
  13. Mol Cancer. 2010 Jul 07;9:179 - PubMed
  14. BMC Bioinformatics. 2006 Aug 04;7:369 - PubMed
  15. Oncotarget. 2013 Mar;4(3):446-62 - PubMed
  16. J Surg Res. 2013 Jun 1;182(1):75-84 - PubMed
  17. PLoS One. 2013 Oct 17;8(10 ):e78262 - PubMed
  18. Ann Surg. 2011 Mar;253(3):453-69 - PubMed
  19. Kidney Int. 2009 Jun;75(12 ):1278-87 - PubMed
  20. Langenbecks Arch Surg. 2010 Apr;395(4):395-405 - PubMed

Publication Types